Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,316Revenue $M10.8Net Margin (%)-1,030.2Z-Score19.4
Enterprise Value $M1,230EPS $-1.2Operating Margin %-1,027.5F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-1,023.7Higher ROA y-yY
Price/Book15.910-y EBITDA Growth Rate %0Quick Ratio3.1Cash flow > EarningsY
Price/Sales1075-y EBITDA Growth Rate %0Current Ratio3.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-93.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-114.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M104ROI % (ttm)-34.8Gross Margin Increase y-yN

Gurus Latest Trades with KERX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
KERXSeth Klarman 2014-09-30 Add1.87%$12.71 - $18.19
($15.32)
$ 12.70-21%Add 73.62%18,300,000
KERXSeth Klarman 2014-06-30 Add1.04%$12.11 - $17.03
($14.16)
$ 12.70-11%Add 67.01%10,539,986
KERXSeth Klarman 2014-03-31 Buy 2.6%$12.16 - $16.88
($14.98)
$ 12.70-18%New holding6,310,850
KERXJohn Burbank 2012-12-31 Sold Out -0.06%$2.31 - $3.14
($2.72)
$ 12.7079%Sold Out0
KERXJohn Burbank 2012-09-30 Buy 0.06%$1.79 - $2.83
($2.08)
$ 12.7084%New holding500,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

KERX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


KERX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Madison GregPresident and COO 2015-03-06Buy6,380$12.531.36view
Madison GregPresident and COO 2015-02-09Sell6,759$10.9515.98view
Oliviero James F IIICFO 2015-01-05Sell5,604$13.79-7.9view
BENTSUR RONCEO 2015-01-05Sell5,574$13.79-7.9view
BENTSUR RONCEO 2014-12-30Sell200,000$14.11-9.99view
BENTSUR RONCEO 2014-12-29Sell338,977$13.98-9.16view
Oliviero James F IIICFO 2014-12-10Sell25,000$15.69-19.06view
BENTSUR RONCEO 2014-10-06Sell70,838$15.88-20.03view
Oliviero James F IIICFO 2014-10-03Sell2,694$16.14-21.31view
BENTSUR RONCEO 2014-09-12Sell50,000$14.24-10.81view

Press Releases about KERX :

    Quarterly/Annual Reports about KERX:

    News about KERX:

    Articles On GuruFocus.com
    Portfolio Feb 17 2015 
    2015 Must-Buys In Biotech Sector Feb 02 2015 
    me Jan 23 2015 
    Seth Klarman Keeps Buying LNG, KERX, PBF And Keeps Selling THRX Dec 05 2014 
    Baupost’s Seth Klarman Buys Cheniere Energy, Ocwen Financial, Antero Resources, Sells Boyd Gaming, Nov 14 2014 
    Seth Klarman’s The Baupost Group Buys eBay, SunEdison Semiconductor, Keryx Biopharmaceuticals, Sel Aug 14 2014 
    Seth Klarman Tops Guru Scoreboard for First Half 2014 Jul 05 2014 
    Baupost’s Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals May 12 2014 
    Weekly Insider Sells Highlight: KERX, ORCL, QCOM, GILD Mar 24 2014 
    Weekly Insider Sells Highlight: FLT, KERX, KOG, MEI, HTZ Jan 06 2014 

    More From Other Websites
    Lightning Round: This was a 'one and done' Mar 26 2015
    Dyadic International Announces The Appointment Of Jack Kaye To Its Board of Directors Mar 18 2015
    Analyzing The Baupost Group’s Holdings in 4Q14 Mar 17 2015
    Billionaire Seth Klarman’s Biotech Stock Picks Mar 15 2015
    Keryx Biopharmaceuticals Announces Appointment of Greg Madison to Its Board of Directors Mar 10 2015
    KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers,... Mar 10 2015
    Keryx Biopharmaceuticals Announces Appointment of Greg Madison to Its Board of Directors Mar 10 2015
    Keryx Biopharmaceuticals Announces Publication of Auryxia(TM) (ferric citrate) Analysis in Journal... Mar 04 2015
    Keryx Announces Fourth Quarter and Year-End 2014 Financial Results Mar 04 2015
    Keryx Biopharmaceuticals Announces Publication of Auryxia(TM) (ferric citrate) Analysis in Journal... Mar 04 2015
    Keryx Biopharmaceuticals' Q4 Loss Wider than Expected - Analyst Blog Mar 02 2015
    Keryx Spotlights Biotech Challenge Mar 02 2015
    Overheard: Keryx’s Value in Profits Mar 02 2015
    Keryx's (KERX) Q4 Loss Misses Expectation, Auryxia in Focus - Tale of the Tape Feb 27 2015
    Keryx Biopharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today Feb 27 2015
    Keryx Biopharma reports 4Q loss Feb 27 2015
    Keryx Biopharma reports 4Q loss Feb 27 2015
    Keryx Biopharmaceuticals Announces Participation at Upcoming Investor Conferences Feb 27 2015
    Q4 2014 Keryx Biopharmaceuticals Inc Earnings Release - Before Market Open Feb 27 2015
    Keryx Announces Fourth Quarter and Year-End 2014 Financial Results Feb 27 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK